Century Therapeutics, Inc. (IPSC) Form 8-K — Jun 16, 2026
Century Therapeutics announced that it entered into an Amended and Restated Employment Agreement with Chief Scientific Officer Chad Cowan, Ph.D., effective June 15, 2026. Dr. Cowan will continue to serve as Chief Scientific Officer on a part-time basis, marking a reduction in his full-time executive status. Under the terms of the new agreement, Dr.
Key figures
- Salary
- 296,150
Price after filing
1 day: +3.2%7 days: +10.6%30 days: -0.5%
Close on the filing date to close N calendar days later (from $2.18). Historical, not a forecast.
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.